Akcea Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 22.377 million compared to USD 26.623 million a year ago. Operating loss was USD 51.091 million compared to USD 38.706 million a year ago. Net loss was USD 49.577 million compared to USD 37.323 million a year ago. For the half year, total revenue was USD 38.451 million compared to USD 190.439 million a year ago. Operating loss was USD 96.350 million compared to USD 12.499 million a year ago. Net loss was USD 92.427 million compared to USD 10.136 million a year ago.